WHYUS
We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.
NewsEvents
Manuel Daldin, Scientist - High Throughput Biology and Screening and Heidi Kingdon Jones, Global VP Business Development are attending the…
The Jenner Institute signs an agreement with Advent to develop a novel coronavirus vaccine
The Jenner Institute, Oxford University, UK and Advent Srl – an IRBM company, Pomezia,Italy - are continuing their long-standing history…
Annual JP Morgan Healthcare Conference
Next week, IRBM’s Vice Presidents, Dan Conlon and Michele Luche will be attending the annual JP Morgan Healthcare Conference –…


















